Edgewise Therapeutics, Inc. (EWTX) Tops Q1 EPS by 3c

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) reported Q1 EPS of ($0.46), $0.03 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Edgewise Therapeutics, Inc. (EWTX) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• Jacobs to advise on New York's $1.7B public health lab
• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings